Market Risers: Morses Club, N4 Pharma, Persimmon, Royal Dutch Shell

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares of Morses Club ticker code: LON:MCL has moved up 9.41% or 4 points during today’s session so far. Market buyers are a positive bunch throughout the trading session. The period high was 47.71 while the low for the session was 42.6. The amount of shares exchanged has so far reached 4,023,219 with the daily average traded share volume around 990,699. The 52 week high price for the shares is 138 which is 95.5 points difference from the previous close and the 52 week low at 15 a difference of some 27.5 points. Morses Club has a 20 day moving average of 37.72 and the 50 day MA at 37.82. The current market cap is £61.03m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Morses Club being recorded at Friday, December 4, 2020 at 11:47:34 AM GMT with the stock price trading at 46.5 GBX.

The share price for N4 Pharma company symbol: LON:N4P has moved up 36.22% or 2.82 points throughout the session so far. Traders seem confident during the session. The period high was 12.75 meanwhile the session low reached 7.4. The amount of shares exchanged has so far reached 17,886,374 while the average shares exchanged is 1,871,662. A 52 week high for the stock is 16 equating to 8.2 points difference from the previous close and the 52 week low at 2 making a difference of 5.8 points. N4 Pharma now has a 20 SMA of 7.01 and now a 50 day simple moving average now at 7.06. Market capitalisation is now £16.58m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for N4 Pharma being recorded at Friday, December 4, 2020 at 11:55:51 AM GMT with the stock price trading at 10.63 GBX.

Shares of Persimmon with company EPIC: LON:PSN has increased 2.77% or 79 points during the course of today’s session so far. Buyers seem confident while the stock has been in play. The periods high figure was 2940 dropping as low as 2803. Volume total for shares traded during this period was 595,862 with the daily average traded share volume around 1,269,546. A 52 week share price high is 3328 which comes in at 474 points difference from the previous days close and the 52 week low at 1367.5 a difference of some 1486.5 points. Persimmon now has a 20 moving average of 2835.57 with a 50 day MA at 2659.28. The current market capitalisation is £9,357.97m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Persimmon being recorded at Friday, December 4, 2020 at 11:55:54 AM GMT with the stock price trading at 2933 GBX.

The stock price for Royal Dutch Shell ticker code: LON:RDSA has risen 2.92% or 39.6 points throughout today’s trading session so far. Investors have remained positive throughout the trading session. The period high was 1403.8 and a low of 1369.2. The volume total for shares traded up to this point was 2,220,505 whilst the average number of shares exchanged is 20,092,282. The 52 week high price for the shares is 2338.59 which is 982.19 points in difference to the previous days close of business and a 52 week low sitting at 878.1 a difference of some 478.3 points. Royal Dutch Shell now has a 20 SMA at 1267.49 and the 50 day SMA of 1101.03. The market capitalisation is now £118,681.71m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Royal Dutch Shell being recorded at Friday, December 4, 2020 at 11:56:30 AM GMT with the stock price trading at 1396 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Persimmon Plc reports strong business momentum with a target of 10,500 home completions for 2024, driven by robust sales and consistent growth.
Persimmon Plc (LON:PSN) reports strong H1 2024 results with a 5% rise in new home completions, robust revenue growth, and enhanced customer satisfaction.
Join N4 Pharma Plc for a pre-recorded webinar on their recent Collaboration Agreement with SRI International Inc. Available on 7 May 2024 at 10:00 BST.
N4 Pharma Plc partners with SRI International to combine Nuvec® with FOX Three MGS, aiming to enhance nucleotide therapies for cancer and vaccines.
N4 Pharma Plc (LON:N4P) unveils its audited results for 2023, showcasing advancements in its innovative Nuvec® delivery system for cancer treatments and vaccines.

Search

Search